Carefusion Corp (CFN) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Goldman Sachs Upgrades CareFusion (CFN) to Neutral
May 6, 2014 6:44 AM EDTGoldman Sachs upgraded CareFusion (NYSE: CFN) from Sell to Neutral with a price target of $40.00 (from $37.00) saying they see post Q3 EPS guidance presenting a more realistic set of expectation.
Analyst David Roman said, "While 3Q14 results missed consensus and GSe, the company... More
